Prognostic implications of gene mutations in acute myeloid leukemia with normal cytogenetics.
about
Acute Myeloid Leukemia: A Concise ReviewRUNX1 mutations are associated with poor outcome in younger and older patients with cytogenetically normal acute myeloid leukemia and with distinct gene and MicroRNA expression signatures.Adult acute erythroleukemia: an analysis of 91 patients treated at a single institutionSignificance of oncogenes and tumor suppressor genes in AML prognosis.Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia.Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemias.Acute myeloid leukemia with IDH1 or IDH2 mutation: frequency and clinicopathologic features.IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.Prevalence and prognostic implications of WT1 mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group.High frequencies of leukemia stem cells in poor-outcome childhood precursor-B acute lymphoblastic leukemias.WT1 synonymous single nucleotide polymorphism rs16754 correlates with higher mRNA expression and predicts significantly improved outcome in favorable-risk pediatric acute myeloid leukemia: a report from the children's oncology groupLeukemic mutations in the methylation-associated genes DNMT3A and IDH2 are rare events in pediatric AML: a report from the Children's Oncology GroupMesenchymal stromal cells of myelodysplastic syndrome and acute myeloid leukemia patients have distinct genetic abnormalities compared with leukemic blasts.Regain control of p53: Targeting leukemia stem cells by isoform-specific HDAC inhibitionHematologic Recovery after Pretransplant Chemotherapy Does Not Influence Survival after Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia Patients.Heterogeneity within AML with CEBPA mutations; only CEBPA double mutations, but not single CEBPA mutations are associated with favourable prognosisOncogenic roles of PRL-3 in FLT3-ITD induced acute myeloid leukaemia.MicroRNAs: new players in acute myeloid leukaemia.Molecular diagnosis of acute myeloid leukemia.Role of allogeneic transplantation for FLT3/ITD acute myeloid leukemia: outcomes from 133 consecutive newly diagnosed patients from a single institution.Prognostic implications of genetic aberrations in acute myelogenous leukemia with normal cytogenetics.Prevalence and Prognostic Value of IDH1 R132 Mutation in Newly Diagnosed AML Egyptian Patients with Normal Karyotype.Standardization of WT1 mRNA quantitation for minimal residual disease monitoring in childhood AML and implications of WT1 gene mutations: a European multicenter study.Molecular analysis of different FLT3-ITD mutations in acute myeloid leukemia.Whole-genome-amplified DNA as a source for mutational analysis underestimates the frequency of mutations in pediatric acute myeloid leukemia.Targeting c-KIT (CD117) by dasatinib and radotinib promotes acute myeloid leukemia cell death.Prevalence and Prognostic Impact of CEBPA Gene Mutation (Simplified Assay Technique) in Egyptian Acute Myeloid Leukemia Patients with Normal Cytogenetics.Genetic mutations in patients with acute myeloid leukemia and leukostasis.Molecular analysis of WT1 and KIT mutations in patients from an Indian population with de novo acute myeloid leukemia: determination of incidence, distribution patterns, and report of a novel KIT mutation.Advances in the drug therapies of acute myeloid leukemia (except acute wpromyelocytic leukemia).
P2860
Q26766719-300F2FDF-D7BE-4974-BEA9-35916AA6400CQ27851839-B4DF98B5-3923-463E-A32C-5299BCD26816Q28258018-661D622C-8C18-46CC-A94B-C6F48C9DE5E0Q30250315-846DC668-21D6-4438-A72C-59AE924FDCC5Q33591867-CB1DDFA8-42B3-4A73-9E21-ABB21432302CQ33647411-92032F23-669D-438A-B02C-9E09A0F90880Q33782633-DF7DFACC-7A35-4529-A9B4-B433067DD565Q33897586-8260EF10-1547-48BD-BD4C-C4E3BD7B44E1Q34052581-CBD88AD4-8990-4289-818F-2D265E7728D1Q34562163-A3B8A72D-C4F4-4084-8E92-228FBF682F1DQ34667832-4BA338C2-8D5B-4C13-8D57-1308B8201024Q35046171-67BA4BBC-9C55-445B-84B9-A8DE5FB63708Q35553350-2D1EC195-C0B2-4FBB-B8F0-5A19B424BAB4Q36827373-0A9EAC92-A662-4E94-8834-553ECD4CB454Q36961604-2EB8D879-BFF4-4EC9-B907-D172CD63C6FBQ37177882-9E33C1FF-BCC0-40A7-876C-DD9689524FA3Q37236903-EFD36E2C-D3CA-4F77-BED4-AD624956473FQ37330733-9F2313A4-C70C-4B68-BBC2-75AE4DF4FA99Q37809866-3C09C9C3-8C3C-448A-B380-E288BAF75F69Q37842861-661FEE2C-BD66-4D46-BC05-F2630A5AAFD4Q37954583-A5288240-8BA0-4F79-8CB3-AA1B1BB60FD2Q38963204-B6DCD551-1054-4A5B-A310-75FFF03B1794Q39992358-4E9AB777-0E7F-4C64-8F29-D0305AD6162BQ45024752-B8CB3CEC-15D0-461B-BF80-3ABB889BA11FQ45114658-D6009F7C-80A7-423C-ADFD-E6D92EE1F898Q46038713-41CBA979-6310-4532-A6F9-414836A9A710Q46531940-976F2B3D-B358-4AE6-A037-4F39FE80AA25Q54440164-B80AD326-4B19-4692-A43D-9ACF55E74A66Q54595724-144F7F50-A814-4B86-8E0B-7E74676657B3Q54964566-A34CE59D-F228-48FE-8C52-1142E1379AD8
P2860
Prognostic implications of gene mutations in acute myeloid leukemia with normal cytogenetics.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prognostic implications of gen ...... emia with normal cytogenetics.
@en
Prognostic implications of gen ...... emia with normal cytogenetics.
@nl
type
label
Prognostic implications of gen ...... emia with normal cytogenetics.
@en
Prognostic implications of gen ...... emia with normal cytogenetics.
@nl
prefLabel
Prognostic implications of gen ...... emia with normal cytogenetics.
@en
Prognostic implications of gen ...... emia with normal cytogenetics.
@nl
P1433
P1476
Prognostic implications of gen ...... emia with normal cytogenetics.
@en
P2093
Verena Gaidzik
P304
P356
10.1053/J.SEMINONCOL.2008.04.005
P577
2008-08-01T00:00:00Z